# Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

> **NCT02215005** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT02215005
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-09
- **Final completion:** —
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215005, "Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02215005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*